Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Comparative Study of Intragastric Balloon and Cognitive-Behavioral Approach for Non-Morbid Obesity (CROSBI ID 227558)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Klobučar Majanović, Sanja ; Ružić, Alen ; Pokrajac Bulian, Alessandra ; Licul, Vanja ; Crnčević Orlić, Željka ; Štimac, Davor Comparative Study of Intragastric Balloon and Cognitive-Behavioral Approach for Non-Morbid Obesity // Hepato-gastroenterology, 61 (2014), 132; 937-941

Podaci o odgovornosti

Klobučar Majanović, Sanja ; Ružić, Alen ; Pokrajac Bulian, Alessandra ; Licul, Vanja ; Crnčević Orlić, Željka ; Štimac, Davor

engleski

Comparative Study of Intragastric Balloon and Cognitive-Behavioral Approach for Non-Morbid Obesity

BACKGROUND/AIMS: Intragastric balloon (IGB) and cognitive- behavioral therapy (CBT) are possible options for weight reduction. The aim of our study was to compare their effectivness in inducing weight loss and metabolic changes accompanying weight loss in non-morbidly obese patients. METHODOLOGY: Subjects were required to be between 18 and 55 years old and to have a BMI between 30 and 45 to be eligible. Exclusion criteria, besides those for IGB placement, were the presence of diabetes, depression, binge- eating disorder and the use of medications that affect body weight. Anthropometric, biochemical and blood pressure measurements were performed at baseline and after 6 months. A total of 114 subjects were recruited to the study and assigned to IGB (n = 60) or CBT group (n = 54). All patients completed the study. RESULTS: After 6 months, patients treated with IGB lost significantly (P < 0.01) more weight (%EWL = 44.6 ± 23.9) than patients who participated in CBT (%EWL = 24.3 ± 16.0). In IGB group 75% of patients achieved ≥ 10% loss of initial weight, and 42.6% of patients in CBT group respectively. A significant improvement in all indices of metabolic syndrome except HDL cholesterol was seen in both treatment groups but much more in subjects treated with IGB. CONCLUSIONS: Our results confirmed that intragastric balloon is useful method for promoting weight loss. Due to improvement of metabolic parameters and substantial benefit on liver function, obese people with metabolic syndrome appear to be the best candidates for IGB placement. Combining intragastric balloon treatment with cognitive- behavioral approach might prove valuable for even greater weight loss.

intragastric balloon ; cognitive-behavioral treatment ; obesity ; weight loss ; metabolic syndrome

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

61 (132)

2014.

937-941

objavljeno

0172-6390

Povezanost rada

Kliničke medicinske znanosti, Psihologija

Indeksiranost